Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-014730

Options or other derivatives

  • CFO and Treasurer acquired 180,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Krognes Steve E. CFO and Treasurer 2018-02-26 Grant or award · Stock Option (right to buy) +180,000 180,000 D
Loading xslF345X03/doc4.xml…